Literature DB >> 25737205

Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013.

Vincent Low1, Yoav Ben-Shlomo2, Elena Coward1, Suzanne Fletcher1, Richard Walker3, Carl E Clarke4.   

Abstract

BACKGROUND: Patients with Parkinson's disease have higher hospital admission rates than the general population. We examined the reasons for admission, length of stay, costs, and in-hospital mortality in a national sample of Parkinson's disease patients.
METHODS: We used hospital admission data from the English Hospital Episodes Statistics database (2009-2013). Patients with Parkinson's disease or Parkinson's disease dementia and aged over 35 years were compared to all other admissions, excluding the above, with the same age criteria. We examined reasons for admissions (ICD-10), length of stay and in-hospital mortality. We used indirect standardisation and Poisson modelling to derive proportional ratios adjusting for age group and sex.
RESULTS: There were 324,055 Parkinson's disease admissions in 182,859 patients over 4 years which included 232,905 non-elective admissions (72%). This resulted in expenditure of £907 million (£777 million for non-elective admissions). The main reasons for admission were pneumonia (13.5%), motor decline (9.4%), urinary tract infection (9.2%), and hip fractures (4.3%). These conditions occurred 1.5 to 2.6 times more frequently in patients than controls. Patients with Parkinson's disease were almost twice as likely to stay in hospital for more than 3 months (ratio 1.90, 95% CI 1.83, 1.97) and even more likely die in hospital (ratio 2.46, 95% CI 2.42, 2.49).
CONCLUSIONS: Parkinson's disease patients in England have higher rates of emergency admissions with longer hospital stays, higher costs and in-hospital mortality. Urgent attention should be given to developing cost-effective interventions to reduce the burden of hospitalisation for patients, carers and healthcare systems.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health economics; Hospitalisation; Mortality; Parkinson's disease

Mesh:

Year:  2015        PMID: 25737205     DOI: 10.1016/j.parkreldis.2015.01.017

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

1.  A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis.

Authors:  Nir Giladi; Anat Mirelman; Avner Thaler; Avi Orr-Urtreger
Journal:  Front Neurol       Date:  2016-05-10       Impact factor: 4.003

2.  What Should Constitute a Health Related Quality of Life Scale for Parkinson's Disease?

Authors:  Rajeev Aggarwal; Vinay Goyal; Ravindra Mohan Pandey; Nand Kumar; Sumit Singh; Garima Shukla; Madhuri Behari
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Comorbid Parkinson's disease, falls and fractures in the 2010 National Emergency Department Sample.

Authors:  Hind A Beydoun; May A Beydoun; Nishant K Mishra; Ola S Rostant; Alan B Zonderman; Shaker M Eid
Journal:  Parkinsonism Relat Disord       Date:  2016-11-19       Impact factor: 4.891

4.  Interdisciplinary palliative care for people with advanced Parkinson's disease: a view from the home.

Authors:  Jori E Fleisher; Ellen C Klostermann; Serena P Hess; Jeanette Lee; Erica Myrick; Joshua Chodosh
Journal:  Ann Palliat Med       Date:  2019-10-14

Review 5.  Diagnosis and Management of Pain in Parkinson's Disease: A New Approach.

Authors:  Veit Mylius; Jens Carsten Möller; Stephan Bohlhalter; Daniel Ciampi de Andrade; Santiago Perez Lloret
Journal:  Drugs Aging       Date:  2021-07-05       Impact factor: 3.923

Review 6.  Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.

Authors:  Cyndya A Shibao; Horacio Kaufmann
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 7.  Lower urinary tract dysfunction in Parkinsonian syndromes.

Authors:  Ekawat Vichayanrat; Claire Hentzen; Amit Batla; Sara Simeoni; Valeria Iodice; Jalesh N Panicker
Journal:  Neurol Sci       Date:  2021-07-28       Impact factor: 3.307

8.  Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists?

Authors:  Unax Lertxundi Etxebarria; Itziar Palacios-Zabalza; Itziar Ibarrondo; Saioa Domingo-Echaburu; Rafael Hernandez; Arantxa Isla; Marian Solinis
Journal:  Eur J Hosp Pharm       Date:  2020-12-22

Review 9.  Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review.

Authors:  Umer Akbar; Robert Brett McQueen; Julienne Bemski; Julie Carter; Elizabeth R Goy; Jean Kutner; Miriam J Johnson; Janis M Miyasaki; Benzi Kluger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-31       Impact factor: 10.154

10.  Remarkably Few Sputum Cultures from People with Parkinson's Disease during Hospital In-Patient Admission.

Authors:  Richard W Walker; Joel English; Grace Tan; Annette Fisher; William K Gray
Journal:  Parkinsons Dis       Date:  2015-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.